Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
RSV Vaccine Efficacy in Pregnancy
Carrie Koenigsfeld, PharmD, FAPhA, highlights the main findings from the MATISSE trial, which evaluated the safety and efficacy of a non-adjuvanted RSV vaccine administered to pregnant women, presenting data that suggests the vaccine's effectiveness in preventing severe RSV in infants and discussing the observed adverse events in both mothers and infants.
EP: 1.Adjuvant RSV Vaccine in Older Adults
EP: 2.Non-adjuvant RSV Vaccine in Older Adults
Now Viewing
EP: 3.RSV Vaccine Efficacy in Pregnancy
EP: 4.Who Not to Vaccinate Against RSV
EP: 5.RSV Vaccine Administration Timing and Errors
EP: 6.Role of the Pharmacist in Vaccinating Against RSV
EP: 7.What is RSV?
EP: 8.Lasting Impacts of RSV
EP: 9.Limiting Transmission of RSV
EP: 10.Preparation of RSV Vaccines
EP: 11.Role of Pharmacists in Improving Vaccine Uptake
EP: 12.Pharmacists Enhancing RSV Care
- What were the key results from the MATISSE trialregarding the safety and efficacy of the non-adjuvanted vaccine in pregnant women?
- Efficacy in preventing severe RSV in infants
- Adverse effects in maternal and infant subjects
- Trial limitations: no high-risk pregnancies
Recent Videos
Related Content
